Endothelin Receptor Antagonists in Kidney Disease

Endothelin (ET) is found to be increased in kidney disease secondary to hyperglycaemia, hypertension, acidosis, and the presence of insulin or proinflammatory cytokines. In this context, ET, via the endothelin receptor type A (ET(A)) activation, causes sustained vasoconstriction of the afferent arte...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Díaz, Irene, Martos, Nerea, Llorens-Cebrià, Carmen, Álvarez, Francisco J., Bedard, Patricia W., Vergara, Ander, Jacobs-Cachá, Conxita, Soler, Maria José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965540/
https://www.ncbi.nlm.nih.gov/pubmed/36834836
http://dx.doi.org/10.3390/ijms24043427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965540/
https://www.ncbi.nlm.nih.gov/pubmed/36834836
http://dx.doi.org/10.3390/ijms24043427

Ejemplares similares